Evaluation of the Efficacy and Tolerability of Acarbose in Patients with Diabetes Mellitus: A Postmarketing Surveillance Study

Author： Spengler M. Schmitz H. Landen H.

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.10, 2005-01, pp. : 651-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Postmarketing Surveillance Study of the Efficacy and Tolerability of Pioglitazone in Insulin-Resistant Patients with Type 2 Diabetes Mellitus in General Practice

By Schöfl C.

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 725-734

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China

By Pan Chang-Yu

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 397-405

Adis International

Access to resources Recommend Favorite

Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus

By Segal Pesach

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 589-595

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang Wu Changgui Li Zhikui Bai Changqing

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite